Dr. Barcenas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-794-5446
Summary
- Associate Professor and Breast Medical Oncologist at MD Anderson Cancer Center in Houston Texas who has a research interest in Survivorship care.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Medical College of GeorgiaResidency, Internal Medicine, 2006 - 2009
Pontifical Xavierian UniversityClass of 1992
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
TN State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2020 - 2025- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy Start of enrollment: 2019 Jan 14
Roles: Principal Investigator, Contact
- Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy Start of enrollment: 2019 Jan 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.Jay P Reddy, Alexander D Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala
International Journal of Radiation Oncology, Biology, Physics. 2024-10-30 - Feasibility Trial of an Online Expressive Writing Intervention for Young Adult Cancer Survivors.Lilian J Shin-Cho, Lenna Dawkins-Moultin, Eunju Choi, Minxing Chen, Carlos H Barcenas
Journal of Adolescent and Young Adult Oncology. 2024-10-28 - Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.Athira Jayan, Jasmine S Sukumar, Benjamin Fangman, Tejal Patel, Akshara Singareeka Raghavendra
JCO Oncology Practice. 2024-10-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
